Skip to main content
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
letter
. 2003 Apr;62(4):368–369. doi: 10.1136/ard.62.4.368

Benefit of anti-TNFα treatment for nephrotic syndrome in a patient with juvenile inflammatory bowel disease associated spondyloarthropathy complicated with amyloidosis and glomerulonephritis

P Verschueren, F Lensen, E Lerut, K Claes, R De Vos, B Van Damme, R Westhovens
PMCID: PMC1754503  PMID: 12634242

Full Text

The Full Text of this article is available as a PDF (153.9 KB).

Figure 1 .

Figure 1

Renal biopsy specimen (A) at baseline and (B) after seven months of treatment. After seven months no decrease in the amount of amyloid is seen despite continuous infliximab treatment. AA stain, x20.

Figure 2 .

Figure 2

Amyloid depositions in glomeruli partly covered by newly formed glomerular basement membrane (x11 500). Inset: amyloid fibrils (x72 500). Arrowhead indicates newly formed basement membrane. E, endothelium; P, podocytes; A, amyloid fibrils.


Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES